Search Results - "Gershlick, A."

Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures by Veitch, A M, Baglin, T P, Gershlick, A H, Harnden, S M, Tighe, R, Cairns, S

Get more information

Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction by Schulz, Stefanie, Richardt, Gert, Laugwitz, Karl-Ludwig, Morath, Tanja, Neudecker, Julia, Hoppmann, Petra, Mehran, Roxana, Gershlick, Anthony H, Tölg, Ralph, Anette Fiedler, K, Abdel-Wahab, Mohamed, Kufner, Sebastian, Schneider, Simon, Schunkert, Heribert, Ibrahim, Tareq, Mehilli, Julinda, Kastrati, Adnan

“…Whether prasugrel plus bivalirudin is a superior strategy to unfractionated heparin plus clopidogrel in patients with ST-segment elevation myocardial…”
Get full text

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The clopidogrel aspirin stent international cooperative study (CLASSICS) by BERTRAND, M. E, RUPPRECHT, H.-J, URBAN, P, GERSHLICK, A. H

“…Combination therapy with the ADP receptor antagonist ticlopidine plus aspirin has emerged as standard care after coronary stenting. Clopidogrel, a new ADP…”
Get full text

Clinical outcomes of patients discharged from the Rapid Access Chest Pain Clinic with non-anginal chest pain: A retrospective cohort study by Kite, T.A., Gaunt, H., Banning, A.S., Roberts, E., Kovac, J., Hudson, I., Gershlick, A.H.

“…The Rapid Access Chest Pain Clinic (RACPC) has become an important means of assessing patients who present with ischaemic or ischaemia-like symptoms of recent…”
Get full text

Drug eluting stents by Gershlick, A H, Richardson, G

“…Dual antiplatelet therapy should not be discontinued without referral to a cardiologist…”
Get full text

Role of non-invasive imaging in the management of coronary artery disease: an assessment of likely change over the next 10 years. A report from the British Cardiovascular Society Working Group by Gershlick, A H, de Belder, M, Chambers, J, Hackett, D, Keal, R, Kelion, A, Neubauer, S, Pennell, D J, Rothman, M, Signy, M, Wilde, P

“…Coronary angiography has been the gold standard for determining the severity, extent and prognosis of coronary atheromatous disease for the past 15–20 years…”
Get full text

Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials by Gershlick, A.H

“…Treating only the specific section of the vascular bed that is diseased appears to make sense. Giving drugs systematically to treat perhaps only a few…”
Get full text

RELATIONSHIP BETWEEN ARTERIAL ACCESS AND OUTCOMES IN A PHARMACOINVASIVE VERSUS PRIMARY PCI STRATEGY IN ST-ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION (STREAM) STUDY by Shavadia, J, Welsh, R, Gershlick, A, Zheng, Y, Huber, K, Halvorsen, S, Steg, P, Van de Werf, F, Armstrong, P.W

Get full text

Drug eluting stents in 2005 by Gershlick, A H

“…[...]there has been an exponential growth of PCI, with worldwide PCI rates exceeding surgical numbers for the last several years. [...]developments in stent…”
Get full text

Clinical trial: chest pain caused by presumed gastro‐oesophageal reflux in coronary artery disease – controlled study of lansoprazole vs. placebo by Talwar, V., Wurm, P., Bankart, M. J. G., Gershlick, A. H., De Caestecker, J. S.

“…Aliment Pharmacol Ther 2010; 32: 191–199 Summary Background  Gastro‐oesophageal reflux (GER) and coronary artery disease commonly co‐exist. Coronary artery…”
Get full text

Dealing with in-stent restenosis by Gershlick, A H, Baron, J

“…The effect of early inhibition leading to late reduction has been used to explain the longer term benefits of reduced clinical events with 7E3 (abciximab;…”
Get full text

Contemporary percutaneous coronary intervention--30 years in the making by Gershlick, A H

“…Angioplasty has come a long way in 30 years. It is now the dominant therapy for obstructive coronary disease and becoming so for acute myocardial infarction…”
Get full text

Clopidogrel induced urticarial rash in a patient with left main stem percutaneous coronary intervention: management issues by Khambekar, S K, Kovac, J, Gershlick, A H

“…Clopidogrel, an ideal treatment for prevention of subacute stent thrombosis, may not be feasible to use in every patient. Ticlopidine (plus aspirin) is a very…”
Get full text

Role of stenting in coronary revascularisation by Gershlick, Anthony H

“…[...]radiation is likely to be incorporated into clinical practice to deal with in-stent restenosis. [...]there is likely to be an increase in the combined…”
Get full text

A multicentre European registry of intraluminal coronary beta brachytherapy by Urban, P., Serruys, P., Baumgart, D., Colombo, A., Silber, S., Eeckhout, E., Gershlick, A., Wegscheider, K., Verhees, L., Bonan, R.

“…Aims To assess the feasibility, safety and effectiveness of intravascular brachytherapy (VBT) in routine clinical practice. Methods and results Between April…”
Get full text

Acute coronary syndromes: optimizing the therapeutic options by Gershlick, A H

Get full text

Failure of intravascular ultrasound to identify the site of recurrent focal coronary spasm during stenting by Azeem, T, Adlam, D, Gershlick, A

“…Focal coronary spasm is often associated with an area of mural plaque disease. This report describes a patient with recurrent severe coronary spasm…”
Get full text

Evolution of vascular brachytherapy over time: Data from the RENO-registry analysis by Azeem, T., Adlam, D., Gershlick, A.

“…To study the evolution of procedural variations in vascular brachytherapy (VBT) and their relationship to medium-term outcome. The RENO (European Surveillance…”
Get full text

Intracoronary stenting: developments since the NICE report by Gershlick, A H

“…The reasons for examining coronary stents were the substantial increase in their use (percutaneous coronary intervention (PCI) procedures: 9933 in 1991, stent…”
Get full text

Blood markers of cardiovascular disease by Gershlick, A H

Get full text